KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) FCF Margin (2016 - 2025)

Historic FCF Margin for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to 33.24%.

  • Edwards Lifesciences' FCF Margin rose 110900.0% to 33.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.67%, marking a year-over-year increase of 39800.0%. This contributed to the annual value of 5.33% for FY2024, which is 75000.0% down from last year.
  • Per Edwards Lifesciences' latest filing, its FCF Margin stood at 33.24% for Q3 2025, which was up 110900.0% from 15.72% recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' FCF Margin ranged from a high of 49.76% in Q4 2022 and a low of 12.79% during Q4 2024
  • Its 5-year average for FCF Margin is 18.47%, with a median of 20.68% in 2023.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 284100bps in 2022, then crashed by -459400bps in 2023.
  • Quarter analysis of 5 years shows Edwards Lifesciences' FCF Margin stood at 21.34% in 2021, then soared by 133bps to 49.76% in 2022, then crashed by -92bps to 3.81% in 2023, then plummeted by -435bps to 12.79% in 2024, then skyrocketed by 360bps to 33.24% in 2025.
  • Its last three reported values are 33.24% in Q3 2025, 15.72% for Q2 2025, and 15.88% during Q1 2025.